Advertisement
Organisation › Details
CVRx Inc.
CVRx is a leader in innovative technologies that address the unmet needs in cardiovascular diseases with safe and effective therapies. Headquartered near Minneapolis, Minn., CVRx is dedicated to improving patient outcomes, quality of life and overall cardiovascular health via novel baroreceptor neuromodulation therapies. *
Start | 2020-07-07 existent | |
Industry | medical device | |
Industry 2 | Barostim Neo™ system | |
Person | Yared, Nadim (CVRx 202007 CEO) | |
Person 2 | Brintnall, John R. (CVRx 202007 CFO) | |
Street | 9201 West Broadway Avenue Suite 650 | |
City | 55445 Minneapolis, MN | |
Tel | +1-763-416-2840 | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | n. a. |
* Document for »About Section«: CVRx, Inc.. (7/7/20). "Press Release: CVRx Raises $50 Million in New Equity Financing. Offering Will Support US Commercialization of Barostem Neo". Minneapolis, MN. | ||
Record changed: 2020-07-11 |
Advertisement
More documents for CVRx Inc.
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top